TMTzu-Yun McDowell

Tzu-Yun McDowell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tzu-Yun McDowell has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Relationship between International Normalized Ratio and Outcomes in Modern Trials with Warfarin Controls

    by Tzu‐Yun McDowell, John Lawrence, Jeffry Florian, Mary Ross Southworth, Stephen Grant, Norman Stockbridge

    A target international normalized ratio (INR) of 2‐3 has been recommended for patients with atrial fibrillation (AF) and risk factors for thromboembolism. This recommendation is largely based on evidence from observational studies a decade ago. This study utilized collective data from modern trials with warfarin controls to examine the relationship of warfarin anticoagulation, as assessed by INR, on the clinical outcome events of interest. Methods Data on warfarin‐treated patients from 3 clinical studies supporting the approval of dabigatran (Pradaxa®), apixaban (Eliquis®), and edoxaban (Savaysa®) were pooled. Ischemic stroke, intracranial hemorrhage (ICH), and all‐cause death were selected as the outcome events of interest. Multivariate Cox regression modeling was performed to examine the association between time‐dependent INR and each outcome event. Benefit‐risk assessment was evaluated by summing the estimated annual event rate for ischemic stroke and ICH. Results A total of 21,883 patients representing 322 ischemic strokes, 288 ICHs, and 657 all‐cause deaths were included in the analysis. The models used suggest that the risk of ischemic stroke is greatly reduced when INR exceeds 2; in contrast, the risk of ICH increases monotonically as INR increases. When combining ischemic stroke and ICH events, the lowest estimated annual event rate was observed between INR of 2 and 2.5; the risk only slightly increased between INR of 1.8 and 3.0. Similarly, a U‐shaped relationship between INR and the risk of all‐cause death was found. Conclusions This study using collective warfarin data from recent large prospective trials indicates that INR between 2 and 2.5 provides the best balance between ischemic stroke and ICH, as well as optimal protection against death in patients with AF.


  • Top Cited Papers
    Open Access

    Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

    by Pamela E. Scott, Ellis F. Unger, Marjorie R. Jenkins, Mary Ross Southworth, Tzu-Yun McDowell, Ruth J. Geller, Merina Elahi, Robert J. Temple, Janet Woodcock


  • Food and Drug Administration Analysis of Ticagrelor

    by Tzu-Yun McDowell, Melanie Blank, John Lawrence, Norman Stockbridge


  • Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis

    by Tzu-Yun McDowell, Sania Amr, William J. Culpepper, Patricia Langenberg, Walter Royal, Christopher Bever, Douglas D. Bradham

    Background: Early life events have been suggested to influence multiple sclerosis (MS) susceptibility, and to potentially modulate its clinical course. We assessed vitamin D-related exposures from childhood to disease onset and their associations with MS progression. Methods: Among veterans in the Multiple Sclerosis Surveillance Registry, 219 reported having the progressive form and met the inclusion criteria. Participants reported their past sun exposure, vitamin D-related intake and age at disability milestones using the Patient-Determined Disease Steps (PDDS). The Cox proportional hazards model was used to examine the association between vitamin D-related exposures and time (years) to disability. Results: Low average sun exposure in the fall/winter before disease onset was associated with an increased risk of progressing to a PDDS score of 8 (hazard ratio, HR: 2.13, 95% confidence interval, CI: 1.20–3.78), whereas use of cod liver oil during childhood and adolescence was associated with a reduced risk (HR: 0.44, 95% CI: 0.20–0.96). Conclusions: These results suggest that exposure to vitamin D before MS onset might slow disease-related neurodegeneration and thus delay progression to disability among patients with the progressive subtype.


  • Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis

    by Tzu-Yun McDowell, Sania Amr, William J. Culpepper, Patricia Langenberg, Walter Royal, Christopher Bever, Douglas D. Bradham

    Background: Current evidence suggests that sun exposure and vitamin D intake, during childhood and adolescence, are associated with a reduced risk of multiple sclerosis (MS). However, the role of these environmental agents in the timing of disease symptom onset remains to be investigated. Methods: Using a cross-sectional study design, we recruited participants from the Veterans Health Administration – Multiple Sclerosis Surveillance Registry. Self-reported histories of residential locations, sun exposure and intake of vitamin D were used to estimate vitamin-D-related exposures. Multivariable linear regression analysis was used to examine the associations between these variables and age at MS onset. Results: Among veterans with relapsing MS who resided in low-to-medium solar radiation areas (n = 540), low sun exposure in the fall/winter during the ages of 6–15 years was significantly associated with earlier symptom onset by 2.1 years (p = 0.02). Intake of cod liver oil during the same age period was associated with later onset of MS symptoms by 4 years (p = 0.02). Conclusions: The current study provides evidence for an association between vitamin-D-related exposures during childhood and early adolescence and the timing of MS symptom onset, and supports vitamin D as a potential modulator of the clinical course of this disease.


  • Time of Birth, Residential Solar Radiation and Age at Onset of Multiple Sclerosis

    by Tzu-Yun McDowell, Sania Amr, Patricia Langenberg, Walter Royal, Christopher Bever, William J. Culpepper, Douglas D. Bradham

    Backgrounds/Aim: Gestational and early life events have been suggested to contribute to multiple sclerosis (MS) susceptibility. We assessed the effects of time and place of birth on the age at onset of MS symptoms. Methods: We selected a national cohort of 967 veterans from the Multiple Sclerosis Surveillance Registry for whom month and season (time) of birth, and birthplace (city and state) were available. Multiple linear regression analyses were used to examine the association between time of birth, birthplace latitude and solar radiation, and the age at onset of MS symptoms among the study sample. Results: Patients with a relapsing form of the disease (R-MS), who were born in winter and whose birthplace was in low solar radiation areas, had disease symptom onset on average 2.8 years earlier than those born in seasons other than winter and in medium- and high-solar radiation areas (p = 0.02). Conclusions: These results suggest that exposure early in life to geographical and seasonal factors, possibly related to the protective effect of sunlight, and thus vitamin D, is associated with a delay in MS symptom onset. Other larger studies are required to examine the period-specific (from conception to adulthood) environmental factors that are associated with MS susceptibility.